Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 1/20 | 0.57 |
| ▸ | CASP7 | P55210 | 1/20 | 0.57 |
| ▸ | CASP6 | P55212 | 1/20 | 0.57 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.53 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GABRP | O00591 | 2/20 | 0.44 |
| ▸ | GABRD | O14764 | 2/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.44 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.44 |
| ▸ | GABRE | P78334 | 2/20 | 0.44 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30762619 | 1.00 | G6PD (0.57) | G6PDCASP7CASP6CLCN2HMGB1 | |
| SCHEMBL17433852 | 0.91 | CLCN2 (0.50) | G6PDCASP7CASP6CLCN2HMGB1 | |
| Fluorobenzene SCHEMBL27572385 | 0.90 | CLCN2 (0.49) | G6PDCASP7CASP6CLCN2HMGB1 | |
| SCHEMBL5135887 | 0.87 | G6PD (0.56) | G6PDCASP7CASP6CLCN2HMGB1 | |
| SCHEMBL4444648 | 0.86 | G6PD (0.59) | G6PDCASP7CASP6CLCN2HMGB1 | |
| SCHEMBL30934865 | 0.86 | G6PD (0.59) | G6PDCASP7CASP6CLCN2HMGB1 | |
| SCHEMBL5965437 | 0.84 | G6PD (0.57) | G6PDCASP7CASP6CLCN2HMGB1 | |
| SCHEMBL3844490 | 0.84 | G6PD (0.57) | G6PDCASP7CASP6CLCN2HMGB1 | |
| SCHEMBL9058759 | 0.84 | GABRA1 (0.45) | CLCN2GABRA1GABRB2ALDH1A1ABCB11 | |
| SCHEMBL3622854 | 0.84 | PARP1 (0.47) | CLCN2GABRA1GABRB2ALDH1A1ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3481589-B1 | ABRASIVE ARTICLES | SAINT GOBAIN ABRASIVES INC (US) | 2023-08-30 | — | — | EP | claimed |
| US-11503831-B2 | Arthropoda repellent composition | SANDERSTROTHMANN GMBH (DE) | 2022-11-22 | — | — | US | claimed |
| CN-113905612-A | Arthropod control composition | 弗门尼舍有限公司 | 2022-01-07 | — | — | CN | claimed |
| EP-3763212-B1 | ARTHROPODA REPELLENT COMPOSITION | SANDERSTROTHMANN GMBH (DE) | 2021-08-18 | — | — | EP | claimed |
| WO-2021005206-A1 | ARTHROPODA REPELLENT COMPOSITION | SANDERSTROTHMANN GMBH (DE) | 2021-01-14 | — | — | WO | claimed |
| US-20210007354-A1 | ARTHROPODA REPELLENT COMPOSITION | SANDERSTROTHMANN GMBH (DE) | 2021-01-14 | — | — | US | claimed |
| EP-3763212-A1 | ARTHROPODA REPELLENT COMPOSITION | SanderStrothmann GmbH (DE) | 2021-01-13 | — | — | EP | claimed |
| WO-2020026143-A1 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2020-02-06 | — | — | WO | claimed |
| US-20200040108-A1 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA | 2020-02-06 | — | — | US | claimed |
| EP-3604346-A1 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | Procter & Gamble International Operations SA (CH) | 2020-02-05 | — | — | EP | claimed |
| US-20140206635-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | IHI CORPORATION (JP) | 2014-07-24 | — | — | US | claimed |
| EP-2738158-A1 | METAL SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC, AND ANTI-MALIGNANT TUMOR AGENT | IHI Corporation (JP) | 2014-06-04 | — | — | EP | claimed |
| CN-102869656-B | Tetrahydrobenzothiophene compound | ASTELLAS PHARMA INC | 2014-03-12 | — | — | CN | claimed |
| US-20140046021-A1 | SELF-MAGNETIC METAL-SALEN COMPLEX COMPOUND | IHI CORPORATION (JP) | 2014-02-13 | — | — | US | claimed |
| EP-2682384-A1 | AUTO-MAGNETIC METAL SALEN COMPLEX COMPOUND | IHI Corporation (JP) | 2014-01-08 | — | — | EP | claimed |
| CN-102869656-A | Tetrahydrobenzothiophene compound | ASTELLAS PHARMA INC | 2013-01-09 | — | — | CN | claimed |
| EP-2239257-B1 | NOVEL QUINAZOLINE-2,4-DIONE DERIVATIVE, AND MEDICAL COMPOSITIONS FOR THE PROPHYLAXIS AND TREATMENT OF CRANIAL NERVE DISEASE CONTAINING THE SAME | SHIN POONG PHARMACEUTICAL CO LTD (KR) | 2012-06-06 | — | — | EP | claimed |
| JP-2005533066-A | — | — | 2005-11-04 | — | — | JP | claimed |
| EP-1527070-A1 | AZOLE METHYLIDENE CYANIDE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS | Applied Research Systems ARS Holding N.V. (AN) | 2005-05-04 | — | — | EP | claimed |
| WO-2003106455-A1 | AZOLE METHYLIDENE CYANIDE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2003-12-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140206635-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | NCLN, KCNN2, NCSTN | G6PD 4113/4885CASP7 1992/4885CASP6 1855/4885 |
| US-20140046021-A1 | SELF-MAGNETIC METAL-SALEN COMPLEX COMPOUND | SSBP1, KCNN1, IMMT | G6PD 2405/4885CASP7 3368/4885CASP6 3174/4885 |
| US-20200040108-A1 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | MGAM, FUT5, FUT6 | G6PD 95/4885CASP7 3747/4885CASP6 3193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.